Universität des Saarlandes (UdS)

University / College


Location: Saarbrücken, Germany (DE) DE

ISNI: 0000000121677588

ROR: https://ror.org/01jdpyv68

Show on Map:


Association analyses of functional NCF1 variants in psoriatic arthritis and psoriasis vulgaris (2019) Hüffmeier U, Löhr S, Ekici AB, Uebe S, Koehm M, Behrens F, Boehm B, et al. Conference contribution Toward coupling color centers in single crystal diamond to two-dimensional materials (2019) Opaluch O, Nelz R, Challier M, Radtke M, Slablab A, Xu Z, Aharonovich I, Neu E Conference contribution IMPACT OF INTERLEUKIN 17 BLOCKING AGENT ON CLINICAL OUTCOME IN SAPHO PATIENTS (2019) Assmann G, Bittenbring JT, Wagner AD, Schreiber M, Christofyllakis K, Hüffmeier U, Pfoehler C, Neumann F Conference contribution Communication as a threat Users' reactions to email and Facebook messages with suspicious links (2019) Gassmann F, Benenson Z, Landwirth R Journal article Ocular changes in nephropathic cystinosis: The course of the gold-dust (2019) Flockerzi E, Daas L, Schlötzer-Schrehardt U, Zimpfer A, Bohle R, Seitz B Journal article, Editorial Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL) (2019) Reinartz G, Pyra RP, Lenz G, Liersch R, Stueben G, Micke O, Willborn K, et al. Journal article Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study (2019) Mavratzas A, Baek S, Gerber B, Schmidt M, Moebus , Foerster F, Grischke EM, et al. Journal article Ultrastructural findings in graft failure after Descemet membrane endothelial keratoplasty (DMEK) and new triple procedure (2019) Schmidt I, Schlötzer-Schrehardt U, Langenbucher A, Eppig T, Hager T, Zimpfer A, Seitz B Journal article Reliability of clinical techniques for evaluating alveolar bone quality and primary implant stability (2019) Karl M, Buder T, Krafft T, Grobecker-Karl T Journal article Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer (2019) Fietkau R, Hecht M, Hofner B, Iro H, Gefeller O, Roedel C, Hautmann M, et al. Conference contribution